SpringWorks Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
22 October 2024 - 10:00PM
SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage
biopharmaceutical company focused on severe rare diseases and
cancer, today announced that it will host a live conference call
and webcast at 8:30 a.m. ET on Tuesday, November 12, 2024 to report
its third quarter financial results and discuss recent business
updates.
To join the live webcast and view the corresponding slides,
please click here. To participate in the live conference call by
phone, please click here to pre-register. Registered participants
will then be provided with a dial-in number and conference code to
access the call. A replay of the webcast will be available for a
limited time following the event on the Investors & Media
section of the Company’s website at
https://ir.springworkstx.com.
About SpringWorks Therapeutics
SpringWorks is a commercial-stage biopharmaceutical company
applying a precision medicine approach to developing and delivering
life-changing medicines for people with severe rare diseases and
cancer. OGSIVEO® (nirogacestat), approved in the United States for
the treatment of adult patients with progressing desmoid tumors who
require systemic treatment, is the Company’s first FDA-approved
therapy. SpringWorks also has a diversified targeted therapy
pipeline spanning solid tumors and hematological cancers, with
programs ranging from preclinical development through advanced
clinical trials. In addition to its wholly owned programs,
SpringWorks has also entered into multiple collaborations with
innovators in industry and academia to unlock the full potential
for its portfolio and create more solutions for patients in
need.
For more information, visit www.springworkstx.com and follow
@SpringWorksTx on X (formerly Twitter), LinkedIn, and YouTube.
Contacts:Investorsinvestors@springworkstx.com
Mediamedia@springworkstx.com
SpringWorks Therapeutics (NASDAQ:SWTX)
Historical Stock Chart
From Oct 2024 to Nov 2024
SpringWorks Therapeutics (NASDAQ:SWTX)
Historical Stock Chart
From Nov 2023 to Nov 2024